Vaccine supply and innovation /:
The United States is facing a vaccine shortage that may threaten public health. This book examines vaccine research and development, production and supply, and utilization and offers recommendations aimed at ensuring vaccine supply and promoting innovation. In addition, this comprehensive volume pro...
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C. :
National Academy Press,
1985.
|
| Schriftenreihe: | IOM publication ;
85-02. |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | The United States is facing a vaccine shortage that may threaten public health. This book examines vaccine research and development, production and supply, and utilization and offers recommendations aimed at ensuring vaccine supply and promoting innovation. In addition, this comprehensive volume provides information on the adverse reactions associated with the range of vaccines used in the United States and contains the most thorough analysis ever published on the state of the law regarding vaccine-related injury and compensation for vaccine injury. |
| Beschreibung: | Title from PDF title page. |
| Beschreibung: | 1 online resource (1 PDF file (xii, 210 pages)) : illustrations. |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 9780309035446 0309035449 0585144915 9780585144917 1280246774 9781280246777 9786610246779 6610246777 0309581524 9780309581523 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocm44964665 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 140806s1985 dcua obt 001 0 eng | ||
| 010 | |a 85060772 | ||
| 040 | |a NLM |b eng |e rda |e pn |c NLM |d N$T |d YDXCP |d COF |d MUX |d OCLCF |d NLGGC |d IDEBK |d INU |d DKDLA |d ADU |d E7B |d FVL |d UV0 |d OCLCO |d OCLCQ |d OCLCO |d AZK |d OCLCQ |d AGLDB |d MND |d MOR |d PIFBR |d OCLCQ |d OCLCA |d BUF |d UUM |d VTS |d VT2 |d WRM |d NRAMU |d INT |d AU@ |d OCLCQ |d WYU |d LVT |d STF |d OCLCE |d UKAHL |d NLM |d OCLCO |d UKCRE |d OCLCO |d QGK |d OCLCQ |d OCL |d INARC |d OCLCO |d OCLCL |d OCLCQ | ||
| 016 | 7 | |a 101641348 |2 DNLM | |
| 019 | |a 70772455 |a 326717292 |a 614598089 |a 647356011 |a 666944450 |a 722244607 |a 728013881 |a 961570788 |a 961603131 |a 962570694 |a 962646356 |a 982316542 |a 988415870 |a 990091823 |a 1003587401 |a 1021262459 |a 1037940615 |a 1064967265 |a 1077756354 |a 1085986339 |a 1153493505 |a 1156406262 |a 1228612334 |a 1249218315 |a 1259210237 |a 1391901950 | ||
| 020 | |a 9780309035446 | ||
| 020 | |a 0309035449 | ||
| 020 | |a 0585144915 | ||
| 020 | |a 9780585144917 | ||
| 020 | |a 1280246774 | ||
| 020 | |a 9781280246777 | ||
| 020 | |a 9786610246779 | ||
| 020 | |a 6610246777 | ||
| 020 | |a 0309581524 | ||
| 020 | |a 9780309581523 | ||
| 035 | |a (OCoLC)44964665 |z (OCoLC)70772455 |z (OCoLC)326717292 |z (OCoLC)614598089 |z (OCoLC)647356011 |z (OCoLC)666944450 |z (OCoLC)722244607 |z (OCoLC)728013881 |z (OCoLC)961570788 |z (OCoLC)961603131 |z (OCoLC)962570694 |z (OCoLC)962646356 |z (OCoLC)982316542 |z (OCoLC)988415870 |z (OCoLC)990091823 |z (OCoLC)1003587401 |z (OCoLC)1021262459 |z (OCoLC)1037940615 |z (OCoLC)1064967265 |z (OCoLC)1077756354 |z (OCoLC)1085986339 |z (OCoLC)1153493505 |z (OCoLC)1156406262 |z (OCoLC)1228612334 |z (OCoLC)1249218315 |z (OCoLC)1259210237 |z (OCoLC)1391901950 | ||
| 042 | |a pcc | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a QR189 |b .V253 1985eb | |
| 060 | 0 | 0 | |a QW 805 |b V1162 1985 |
| 070 | |a RM281.V33 | ||
| 072 | 7 | |a MED |x 037000 |2 bisacsh | |
| 072 | 7 | |a MED |x 028000 |2 bisacsh | |
| 072 | 0 | |a X380 | |
| 082 | 7 | |a 614.4/7/0973 |2 20 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Vaccine supply and innovation / |c Division of Health Promotion and Disease Prevention, Institute of Medicine. |
| 264 | 1 | |a Washington, D.C. : |b National Academy Press, |c 1985. | |
| 300 | |a 1 online resource (1 PDF file (xii, 210 pages)) : |b illustrations. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file |2 rda | ||
| 490 | 1 | |a Publication IOM ; |v 85-02 | |
| 500 | |a Title from PDF title page. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 520 | 3 | |a The United States is facing a vaccine shortage that may threaten public health. This book examines vaccine research and development, production and supply, and utilization and offers recommendations aimed at ensuring vaccine supply and promoting innovation. In addition, this comprehensive volume provides information on the adverse reactions associated with the range of vaccines used in the United States and contains the most thorough analysis ever published on the state of the law regarding vaccine-related injury and compensation for vaccine injury. | |
| 536 | |a The study was supported under contracts with the Food and Drug Administration (223-83-1109), the Department of the Army (DAMD17-83-G-9558), and the Centers for Disease Control (200-83-0609), and grants from Lederle Laboratories, the Mericux Institute, Inc., and Merck Sharp & Dohme. Additional support was provided by the National Research Council (NRC) Fund, a pool of private, discretionary, nonfederal funds that is used to support a program of Academy-initiated studies of national issues in which science and technology figure significantly. The NRC Fund consists of contributions from a consortium of private foundations including the Carnegie Corporation of New York, the Charles E. Culpeper Foundation, the William and Flora Hewlett Foundation, the John D. and Catherine T. MacArthur Foundation, the Andrew W. Mellon Foundation, the Rockefeller Foundation, and the Alfred P. Sloan Foundation; the Academy Industry Program, which seeks annual contributions from companies that are concerned with the health of U.S. science and technology and with public policy issues with technological content; and the National Academy of Sciences and the National Academy of Engineering endowments. | ||
| 588 | 0 | |a Version viewed October 14, 2014. | |
| 505 | 0 | |a ""Vaccine Supply and Innovation""; ""Copyright""; ""Preface""; ""Contents""; ""Vaccine Supply and Innovation""; ""1 Summary""; ""OVERVIEW""; ""VACCINE AVAILABILITY: MAJOR BARRIERS AND IMPEDIMENTS""; ""Impediments to Vaccine Innovation""; ""ECONOMIC CHARACTERISTICS OF THE VACCINE INDUSTRY""; ""VACCINE INJURY""; ""THE LEGAL SITUATION AND ITS CONSEQUENCES""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""A NATIONAL VACCINE COMMISSION""; ""COMPENSATION AND LIABILITY FOR VACCINE-RELATED INJURY""; ""2 Vaccines: Past, Present, and Future"" | |
| 505 | 8 | |a ""TYPES OF IMMUNIZATION""""HISTORY OF IMMUNIZATION""; ""THE PRESENT""; ""Development of Vaccines and Recommendations for Vaccine Use""; ""THE FUTURE""; ""REFERENCES AND NOTES""; ""3 Vaccine Availability: Concerns, Barriers, and Impediments""; ""CONCERNS ABOUT THE CURRENT SITUATION""; ""Supply""; ""Stockpiling of Vaccines""; ""Problems with Sole Reliance on Foreign Manufacturers""; ""Federal Action to Ensure Vaccine Supply""; ""BARRIERS AND IMPEDIMENTS TO VACCINE INNOVATION""; ""Identification of Need and Establishing Priorities"" | |
| 505 | 8 | |a ""Establishing the Technical Feasibility of Vaccine Development""""Economic Disincentives to Innovation and Production""; ""Factors Influencing the Market for Vaccines""; ""VACCINE UTILIZATION""; ""System Factors""; ""Client Factors""; ""Provider Factors""; ""CONCLUSIONS""; ""Barriers and Impediments to Vaccine Innovation""; ""REFERENCES AND NOTES""; ""4 Economic Aspects of Vaccine Innovation and Manufacturing""; ""POTENTIAL CAUSES OF INDUSTRY DECLINE""; ""Property Rights and Innovation""; ""Regulation""; ""Market Size""; ""Liability and Risk""; ""DESCRIPTIVE STATISTICS"" | |
| 505 | 8 | |a ""The Market and Participants""""Pricing""; ""Research and Development""; ""CONCLUSIONS""; ""REFERENCES AND NOTES""; ""5 Vaccine Injury""; ""The Pertussis Controversy""; ""Identifying Individuals at High Risk of Adverse Effects""; ""VACCINES USED IN CHILDHOOD""; ""Pertussis Vaccine""; ""Diphtheria Toxoid""; ""Tetanus Toxoid""; ""Poliomyelitis Vaccines""; ""Measles Vaccine""; ""Rubella Vaccine""; ""Mumps Vaccine""; ""VACCINES FOR ADULTS""; ""Influenza Vaccines""; ""Pneumococcal Vaccines""; ""Meningococcal Vaccines""; ""Rabies Vaccine""; ""Hepatitis B Vaccine""; ""SUMMARY"" | |
| 546 | |a English. | ||
| 650 | 0 | |a Vaccines |x Government policy |z United States. | |
| 650 | 0 | |a Vaccines |x Technological innovations. | |
| 650 | 0 | |a Vaccination |x Complications. |0 http://id.loc.gov/authorities/subjects/sh85141710 | |
| 650 | 0 | |a Medical policy. |0 http://id.loc.gov/authorities/subjects/sh85083002 | |
| 650 | 1 | 2 | |a Vaccines |x supply & distribution |0 https://id.nlm.nih.gov/mesh/D014612Q000600 |
| 650 | 2 | 2 | |a Vaccination |x trends |0 https://id.nlm.nih.gov/mesh/D014611Q000639 |
| 650 | 2 | 2 | |a Vaccination |x adverse effects |0 https://id.nlm.nih.gov/mesh/D014611Q000009 |
| 650 | 2 | 2 | |a Health Policy |0 https://id.nlm.nih.gov/mesh/D006291 |
| 651 | 2 | |a United States |0 https://id.nlm.nih.gov/mesh/D014481 | |
| 650 | 6 | |a Vaccins |x Politique gouvernementale |z États-Unis. | |
| 650 | 6 | |a Vaccins |x Innovations. | |
| 650 | 6 | |a Vaccination |x Complications et séquelles. | |
| 650 | 6 | |a Politique sanitaire. | |
| 650 | 7 | |a MEDICAL |x Health Risk Assessment. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Epidemiology. |2 bisacsh | |
| 650 | 7 | |a Vaccination |x Complications |2 fast | |
| 650 | 7 | |a Medical policy |2 fast | |
| 650 | 7 | |a Vaccines |x Government policy |2 fast | |
| 650 | 7 | |a Vaccines |x Technological innovations |2 fast | |
| 651 | 7 | |a United States |2 fast | |
| 700 | 1 | |a Osborn, June E., |d 1937- |e donor. |5 DNLM |0 http://id.loc.gov/authorities/names/n89102362 | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Division of Health Promotion and Disease Prevention, |e author, |e issuing body. |0 http://id.loc.gov/authorities/names/n80156868 | |
| 776 | 0 | 8 | |i Print version: |t Vaccine supply and innovation. |d Washington, D.C. : National Academy Press, 1985 |z 0309035449 |w (DLC) 85060772 |w (OCoLC)12642659 |
| 830 | 0 | |a IOM publication ; |v 85-02. |0 http://id.loc.gov/authorities/names/n42031273 | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=14728 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36567012 | ||
| 938 | |a ebrary |b EBRY |n ebr10055083 | ||
| 938 | |a EBSCOhost |b EBSC |n 14728 | ||
| 938 | |a YBP Library Services |b YANK |n 2309250 | ||
| 938 | |a YBP Library Services |b YANK |n 6012491 | ||
| 938 | |a Internet Archive |b INAR |n vaccinesupplyinn0000unse | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocm44964665 |
|---|---|
| _version_ | 1816881589637873665 |
| adam_text | |
| any_adam_object | |
| author_GND | http://id.loc.gov/authorities/names/n89102362 |
| author_corporate | Institute of Medicine (U.S.). Division of Health Promotion and Disease Prevention |
| author_corporate_role | aut |
| author_facet | Institute of Medicine (U.S.). Division of Health Promotion and Disease Prevention |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | Q - Science |
| callnumber-label | QR189 |
| callnumber-raw | QR189 .V253 1985eb |
| callnumber-search | QR189 .V253 1985eb |
| callnumber-sort | QR 3189 V253 41985EB |
| callnumber-subject | QR - Microbiology |
| collection | ZDB-4-EBA |
| contents | ""Vaccine Supply and Innovation""; ""Copyright""; ""Preface""; ""Contents""; ""Vaccine Supply and Innovation""; ""1 Summary""; ""OVERVIEW""; ""VACCINE AVAILABILITY: MAJOR BARRIERS AND IMPEDIMENTS""; ""Impediments to Vaccine Innovation""; ""ECONOMIC CHARACTERISTICS OF THE VACCINE INDUSTRY""; ""VACCINE INJURY""; ""THE LEGAL SITUATION AND ITS CONSEQUENCES""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""A NATIONAL VACCINE COMMISSION""; ""COMPENSATION AND LIABILITY FOR VACCINE-RELATED INJURY""; ""2 Vaccines: Past, Present, and Future"" ""TYPES OF IMMUNIZATION""""HISTORY OF IMMUNIZATION""; ""THE PRESENT""; ""Development of Vaccines and Recommendations for Vaccine Use""; ""THE FUTURE""; ""REFERENCES AND NOTES""; ""3 Vaccine Availability: Concerns, Barriers, and Impediments""; ""CONCERNS ABOUT THE CURRENT SITUATION""; ""Supply""; ""Stockpiling of Vaccines""; ""Problems with Sole Reliance on Foreign Manufacturers""; ""Federal Action to Ensure Vaccine Supply""; ""BARRIERS AND IMPEDIMENTS TO VACCINE INNOVATION""; ""Identification of Need and Establishing Priorities"" ""Establishing the Technical Feasibility of Vaccine Development""""Economic Disincentives to Innovation and Production""; ""Factors Influencing the Market for Vaccines""; ""VACCINE UTILIZATION""; ""System Factors""; ""Client Factors""; ""Provider Factors""; ""CONCLUSIONS""; ""Barriers and Impediments to Vaccine Innovation""; ""REFERENCES AND NOTES""; ""4 Economic Aspects of Vaccine Innovation and Manufacturing""; ""POTENTIAL CAUSES OF INDUSTRY DECLINE""; ""Property Rights and Innovation""; ""Regulation""; ""Market Size""; ""Liability and Risk""; ""DESCRIPTIVE STATISTICS"" ""The Market and Participants""""Pricing""; ""Research and Development""; ""CONCLUSIONS""; ""REFERENCES AND NOTES""; ""5 Vaccine Injury""; ""The Pertussis Controversy""; ""Identifying Individuals at High Risk of Adverse Effects""; ""VACCINES USED IN CHILDHOOD""; ""Pertussis Vaccine""; ""Diphtheria Toxoid""; ""Tetanus Toxoid""; ""Poliomyelitis Vaccines""; ""Measles Vaccine""; ""Rubella Vaccine""; ""Mumps Vaccine""; ""VACCINES FOR ADULTS""; ""Influenza Vaccines""; ""Pneumococcal Vaccines""; ""Meningococcal Vaccines""; ""Rabies Vaccine""; ""Hepatitis B Vaccine""; ""SUMMARY"" |
| ctrlnum | (OCoLC)44964665 |
| dewey-full | 614.4/7/0973 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 614 - Forensic medicine; incidence of disease |
| dewey-raw | 614.4/7/0973 |
| dewey-search | 614.4/7/0973 |
| dewey-sort | 3614.4 17 3973 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>08968cam a2200997 i 4500</leader><controlfield tag="001">ZDB-4-EBA-ocm44964665 </controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">140806s1985 dcua obt 001 0 eng </controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 85060772 </subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NLM</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">NLM</subfield><subfield code="d">N$T</subfield><subfield code="d">YDXCP</subfield><subfield code="d">COF</subfield><subfield code="d">MUX</subfield><subfield code="d">OCLCF</subfield><subfield code="d">NLGGC</subfield><subfield code="d">IDEBK</subfield><subfield code="d">INU</subfield><subfield code="d">DKDLA</subfield><subfield code="d">ADU</subfield><subfield code="d">E7B</subfield><subfield code="d">FVL</subfield><subfield code="d">UV0</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AZK</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AGLDB</subfield><subfield code="d">MND</subfield><subfield code="d">MOR</subfield><subfield code="d">PIFBR</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">BUF</subfield><subfield code="d">UUM</subfield><subfield code="d">VTS</subfield><subfield code="d">VT2</subfield><subfield code="d">WRM</subfield><subfield code="d">NRAMU</subfield><subfield code="d">INT</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">WYU</subfield><subfield code="d">LVT</subfield><subfield code="d">STF</subfield><subfield code="d">OCLCE</subfield><subfield code="d">UKAHL</subfield><subfield code="d">NLM</subfield><subfield code="d">OCLCO</subfield><subfield code="d">UKCRE</subfield><subfield code="d">OCLCO</subfield><subfield code="d">QGK</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCL</subfield><subfield code="d">INARC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">101641348</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">70772455</subfield><subfield code="a">326717292</subfield><subfield code="a">614598089</subfield><subfield code="a">647356011</subfield><subfield code="a">666944450</subfield><subfield code="a">722244607</subfield><subfield code="a">728013881</subfield><subfield code="a">961570788</subfield><subfield code="a">961603131</subfield><subfield code="a">962570694</subfield><subfield code="a">962646356</subfield><subfield code="a">982316542</subfield><subfield code="a">988415870</subfield><subfield code="a">990091823</subfield><subfield code="a">1003587401</subfield><subfield code="a">1021262459</subfield><subfield code="a">1037940615</subfield><subfield code="a">1064967265</subfield><subfield code="a">1077756354</subfield><subfield code="a">1085986339</subfield><subfield code="a">1153493505</subfield><subfield code="a">1156406262</subfield><subfield code="a">1228612334</subfield><subfield code="a">1249218315</subfield><subfield code="a">1259210237</subfield><subfield code="a">1391901950</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309035446</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309035449</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0585144915</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780585144917</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1280246774</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781280246777</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9786610246779</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">6610246777</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309581524</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309581523</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)44964665</subfield><subfield code="z">(OCoLC)70772455</subfield><subfield code="z">(OCoLC)326717292</subfield><subfield code="z">(OCoLC)614598089</subfield><subfield code="z">(OCoLC)647356011</subfield><subfield code="z">(OCoLC)666944450</subfield><subfield code="z">(OCoLC)722244607</subfield><subfield code="z">(OCoLC)728013881</subfield><subfield code="z">(OCoLC)961570788</subfield><subfield code="z">(OCoLC)961603131</subfield><subfield code="z">(OCoLC)962570694</subfield><subfield code="z">(OCoLC)962646356</subfield><subfield code="z">(OCoLC)982316542</subfield><subfield code="z">(OCoLC)988415870</subfield><subfield code="z">(OCoLC)990091823</subfield><subfield code="z">(OCoLC)1003587401</subfield><subfield code="z">(OCoLC)1021262459</subfield><subfield code="z">(OCoLC)1037940615</subfield><subfield code="z">(OCoLC)1064967265</subfield><subfield code="z">(OCoLC)1077756354</subfield><subfield code="z">(OCoLC)1085986339</subfield><subfield code="z">(OCoLC)1153493505</subfield><subfield code="z">(OCoLC)1156406262</subfield><subfield code="z">(OCoLC)1228612334</subfield><subfield code="z">(OCoLC)1249218315</subfield><subfield code="z">(OCoLC)1259210237</subfield><subfield code="z">(OCoLC)1391901950</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">pcc</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">n-us---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QR189</subfield><subfield code="b">.V253 1985eb</subfield></datafield><datafield tag="060" ind1="0" ind2="0"><subfield code="a">QW 805</subfield><subfield code="b">V1162 1985</subfield></datafield><datafield tag="070" ind1=" " ind2=" "><subfield code="a">RM281.V33</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">037000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">028000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="0"><subfield code="a">X380</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">614.4/7/0973</subfield><subfield code="2">20</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Vaccine supply and innovation /</subfield><subfield code="c">Division of Health Promotion and Disease Prevention, Institute of Medicine.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C. :</subfield><subfield code="b">National Academy Press,</subfield><subfield code="c">1985.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (1 PDF file (xii, 210 pages)) :</subfield><subfield code="b">illustrations.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">data file</subfield><subfield code="2">rda</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Publication IOM ;</subfield><subfield code="v">85-02</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from PDF title page.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">The United States is facing a vaccine shortage that may threaten public health. This book examines vaccine research and development, production and supply, and utilization and offers recommendations aimed at ensuring vaccine supply and promoting innovation. In addition, this comprehensive volume provides information on the adverse reactions associated with the range of vaccines used in the United States and contains the most thorough analysis ever published on the state of the law regarding vaccine-related injury and compensation for vaccine injury.</subfield></datafield><datafield tag="536" ind1=" " ind2=" "><subfield code="a">The study was supported under contracts with the Food and Drug Administration (223-83-1109), the Department of the Army (DAMD17-83-G-9558), and the Centers for Disease Control (200-83-0609), and grants from Lederle Laboratories, the Mericux Institute, Inc., and Merck Sharp & Dohme. Additional support was provided by the National Research Council (NRC) Fund, a pool of private, discretionary, nonfederal funds that is used to support a program of Academy-initiated studies of national issues in which science and technology figure significantly. The NRC Fund consists of contributions from a consortium of private foundations including the Carnegie Corporation of New York, the Charles E. Culpeper Foundation, the William and Flora Hewlett Foundation, the John D. and Catherine T. MacArthur Foundation, the Andrew W. Mellon Foundation, the Rockefeller Foundation, and the Alfred P. Sloan Foundation; the Academy Industry Program, which seeks annual contributions from companies that are concerned with the health of U.S. science and technology and with public policy issues with technological content; and the National Academy of Sciences and the National Academy of Engineering endowments.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Version viewed October 14, 2014.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">""Vaccine Supply and Innovation""; ""Copyright""; ""Preface""; ""Contents""; ""Vaccine Supply and Innovation""; ""1 Summary""; ""OVERVIEW""; ""VACCINE AVAILABILITY: MAJOR BARRIERS AND IMPEDIMENTS""; ""Impediments to Vaccine Innovation""; ""ECONOMIC CHARACTERISTICS OF THE VACCINE INDUSTRY""; ""VACCINE INJURY""; ""THE LEGAL SITUATION AND ITS CONSEQUENCES""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""A NATIONAL VACCINE COMMISSION""; ""COMPENSATION AND LIABILITY FOR VACCINE-RELATED INJURY""; ""2 Vaccines: Past, Present, and Future""</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">""TYPES OF IMMUNIZATION""""HISTORY OF IMMUNIZATION""; ""THE PRESENT""; ""Development of Vaccines and Recommendations for Vaccine Use""; ""THE FUTURE""; ""REFERENCES AND NOTES""; ""3 Vaccine Availability: Concerns, Barriers, and Impediments""; ""CONCERNS ABOUT THE CURRENT SITUATION""; ""Supply""; ""Stockpiling of Vaccines""; ""Problems with Sole Reliance on Foreign Manufacturers""; ""Federal Action to Ensure Vaccine Supply""; ""BARRIERS AND IMPEDIMENTS TO VACCINE INNOVATION""; ""Identification of Need and Establishing Priorities""</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">""Establishing the Technical Feasibility of Vaccine Development""""Economic Disincentives to Innovation and Production""; ""Factors Influencing the Market for Vaccines""; ""VACCINE UTILIZATION""; ""System Factors""; ""Client Factors""; ""Provider Factors""; ""CONCLUSIONS""; ""Barriers and Impediments to Vaccine Innovation""; ""REFERENCES AND NOTES""; ""4 Economic Aspects of Vaccine Innovation and Manufacturing""; ""POTENTIAL CAUSES OF INDUSTRY DECLINE""; ""Property Rights and Innovation""; ""Regulation""; ""Market Size""; ""Liability and Risk""; ""DESCRIPTIVE STATISTICS""</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">""The Market and Participants""""Pricing""; ""Research and Development""; ""CONCLUSIONS""; ""REFERENCES AND NOTES""; ""5 Vaccine Injury""; ""The Pertussis Controversy""; ""Identifying Individuals at High Risk of Adverse Effects""; ""VACCINES USED IN CHILDHOOD""; ""Pertussis Vaccine""; ""Diphtheria Toxoid""; ""Tetanus Toxoid""; ""Poliomyelitis Vaccines""; ""Measles Vaccine""; ""Rubella Vaccine""; ""Mumps Vaccine""; ""VACCINES FOR ADULTS""; ""Influenza Vaccines""; ""Pneumococcal Vaccines""; ""Meningococcal Vaccines""; ""Rabies Vaccine""; ""Hepatitis B Vaccine""; ""SUMMARY""</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Vaccines</subfield><subfield code="x">Government policy</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Vaccines</subfield><subfield code="x">Technological innovations.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Vaccination</subfield><subfield code="x">Complications.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85141710</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical policy.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85083002</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Vaccines</subfield><subfield code="x">supply & distribution</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D014612Q000600</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Vaccination</subfield><subfield code="x">trends</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D014611Q000639</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Vaccination</subfield><subfield code="x">adverse effects</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D014611Q000009</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Health Policy</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D006291</subfield></datafield><datafield tag="651" ind1=" " ind2="2"><subfield code="a">United States</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D014481</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Vaccins</subfield><subfield code="x">Politique gouvernementale</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Vaccins</subfield><subfield code="x">Innovations.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Vaccination</subfield><subfield code="x">Complications et séquelles.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Politique sanitaire.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Health Risk Assessment.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Epidemiology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccination</subfield><subfield code="x">Complications</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medical policy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccines</subfield><subfield code="x">Government policy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccines</subfield><subfield code="x">Technological innovations</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">United States</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Osborn, June E.,</subfield><subfield code="d">1937-</subfield><subfield code="e">donor.</subfield><subfield code="5">DNLM</subfield><subfield code="0">http://id.loc.gov/authorities/names/n89102362</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Division of Health Promotion and Disease Prevention,</subfield><subfield code="e">author,</subfield><subfield code="e">issuing body.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n80156868</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Vaccine supply and innovation.</subfield><subfield code="d">Washington, D.C. : National Academy Press, 1985</subfield><subfield code="z">0309035449</subfield><subfield code="w">(DLC) 85060772</subfield><subfield code="w">(OCoLC)12642659</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">IOM publication ;</subfield><subfield code="v">85-02.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n42031273</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=14728</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36567012</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10055083</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">14728</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">2309250</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">6012491</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Internet Archive</subfield><subfield code="b">INAR</subfield><subfield code="n">vaccinesupplyinn0000unse</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| geographic | United States https://id.nlm.nih.gov/mesh/D014481 United States fast |
| geographic_facet | United States |
| id | ZDB-4-EBA-ocm44964665 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:15:07Z |
| institution | BVB |
| institution_GND | http://id.loc.gov/authorities/names/n80156868 |
| isbn | 9780309035446 0309035449 0585144915 9780585144917 1280246774 9781280246777 9786610246779 6610246777 0309581524 9780309581523 |
| language | English |
| lccn | 85060772 |
| oclc_num | 44964665 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (1 PDF file (xii, 210 pages)) : illustrations. |
| psigel | ZDB-4-EBA |
| publishDate | 1985 |
| publishDateSearch | 1985 |
| publishDateSort | 1985 |
| publisher | National Academy Press, |
| record_format | marc |
| series | IOM publication ; |
| series2 | Publication IOM ; |
| spelling | Vaccine supply and innovation / Division of Health Promotion and Disease Prevention, Institute of Medicine. Washington, D.C. : National Academy Press, 1985. 1 online resource (1 PDF file (xii, 210 pages)) : illustrations. text txt rdacontent computer c rdamedia online resource cr rdacarrier data file rda Publication IOM ; 85-02 Title from PDF title page. Includes bibliographical references and index. The United States is facing a vaccine shortage that may threaten public health. This book examines vaccine research and development, production and supply, and utilization and offers recommendations aimed at ensuring vaccine supply and promoting innovation. In addition, this comprehensive volume provides information on the adverse reactions associated with the range of vaccines used in the United States and contains the most thorough analysis ever published on the state of the law regarding vaccine-related injury and compensation for vaccine injury. The study was supported under contracts with the Food and Drug Administration (223-83-1109), the Department of the Army (DAMD17-83-G-9558), and the Centers for Disease Control (200-83-0609), and grants from Lederle Laboratories, the Mericux Institute, Inc., and Merck Sharp & Dohme. Additional support was provided by the National Research Council (NRC) Fund, a pool of private, discretionary, nonfederal funds that is used to support a program of Academy-initiated studies of national issues in which science and technology figure significantly. The NRC Fund consists of contributions from a consortium of private foundations including the Carnegie Corporation of New York, the Charles E. Culpeper Foundation, the William and Flora Hewlett Foundation, the John D. and Catherine T. MacArthur Foundation, the Andrew W. Mellon Foundation, the Rockefeller Foundation, and the Alfred P. Sloan Foundation; the Academy Industry Program, which seeks annual contributions from companies that are concerned with the health of U.S. science and technology and with public policy issues with technological content; and the National Academy of Sciences and the National Academy of Engineering endowments. Version viewed October 14, 2014. ""Vaccine Supply and Innovation""; ""Copyright""; ""Preface""; ""Contents""; ""Vaccine Supply and Innovation""; ""1 Summary""; ""OVERVIEW""; ""VACCINE AVAILABILITY: MAJOR BARRIERS AND IMPEDIMENTS""; ""Impediments to Vaccine Innovation""; ""ECONOMIC CHARACTERISTICS OF THE VACCINE INDUSTRY""; ""VACCINE INJURY""; ""THE LEGAL SITUATION AND ITS CONSEQUENCES""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""A NATIONAL VACCINE COMMISSION""; ""COMPENSATION AND LIABILITY FOR VACCINE-RELATED INJURY""; ""2 Vaccines: Past, Present, and Future"" ""TYPES OF IMMUNIZATION""""HISTORY OF IMMUNIZATION""; ""THE PRESENT""; ""Development of Vaccines and Recommendations for Vaccine Use""; ""THE FUTURE""; ""REFERENCES AND NOTES""; ""3 Vaccine Availability: Concerns, Barriers, and Impediments""; ""CONCERNS ABOUT THE CURRENT SITUATION""; ""Supply""; ""Stockpiling of Vaccines""; ""Problems with Sole Reliance on Foreign Manufacturers""; ""Federal Action to Ensure Vaccine Supply""; ""BARRIERS AND IMPEDIMENTS TO VACCINE INNOVATION""; ""Identification of Need and Establishing Priorities"" ""Establishing the Technical Feasibility of Vaccine Development""""Economic Disincentives to Innovation and Production""; ""Factors Influencing the Market for Vaccines""; ""VACCINE UTILIZATION""; ""System Factors""; ""Client Factors""; ""Provider Factors""; ""CONCLUSIONS""; ""Barriers and Impediments to Vaccine Innovation""; ""REFERENCES AND NOTES""; ""4 Economic Aspects of Vaccine Innovation and Manufacturing""; ""POTENTIAL CAUSES OF INDUSTRY DECLINE""; ""Property Rights and Innovation""; ""Regulation""; ""Market Size""; ""Liability and Risk""; ""DESCRIPTIVE STATISTICS"" ""The Market and Participants""""Pricing""; ""Research and Development""; ""CONCLUSIONS""; ""REFERENCES AND NOTES""; ""5 Vaccine Injury""; ""The Pertussis Controversy""; ""Identifying Individuals at High Risk of Adverse Effects""; ""VACCINES USED IN CHILDHOOD""; ""Pertussis Vaccine""; ""Diphtheria Toxoid""; ""Tetanus Toxoid""; ""Poliomyelitis Vaccines""; ""Measles Vaccine""; ""Rubella Vaccine""; ""Mumps Vaccine""; ""VACCINES FOR ADULTS""; ""Influenza Vaccines""; ""Pneumococcal Vaccines""; ""Meningococcal Vaccines""; ""Rabies Vaccine""; ""Hepatitis B Vaccine""; ""SUMMARY"" English. Vaccines Government policy United States. Vaccines Technological innovations. Vaccination Complications. http://id.loc.gov/authorities/subjects/sh85141710 Medical policy. http://id.loc.gov/authorities/subjects/sh85083002 Vaccines supply & distribution https://id.nlm.nih.gov/mesh/D014612Q000600 Vaccination trends https://id.nlm.nih.gov/mesh/D014611Q000639 Vaccination adverse effects https://id.nlm.nih.gov/mesh/D014611Q000009 Health Policy https://id.nlm.nih.gov/mesh/D006291 United States https://id.nlm.nih.gov/mesh/D014481 Vaccins Politique gouvernementale États-Unis. Vaccins Innovations. Vaccination Complications et séquelles. Politique sanitaire. MEDICAL Health Risk Assessment. bisacsh MEDICAL Epidemiology. bisacsh Vaccination Complications fast Medical policy fast Vaccines Government policy fast Vaccines Technological innovations fast United States fast Osborn, June E., 1937- donor. DNLM http://id.loc.gov/authorities/names/n89102362 Institute of Medicine (U.S.). Division of Health Promotion and Disease Prevention, author, issuing body. http://id.loc.gov/authorities/names/n80156868 Print version: Vaccine supply and innovation. Washington, D.C. : National Academy Press, 1985 0309035449 (DLC) 85060772 (OCoLC)12642659 IOM publication ; 85-02. http://id.loc.gov/authorities/names/n42031273 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=14728 Volltext |
| spellingShingle | Vaccine supply and innovation / IOM publication ; ""Vaccine Supply and Innovation""; ""Copyright""; ""Preface""; ""Contents""; ""Vaccine Supply and Innovation""; ""1 Summary""; ""OVERVIEW""; ""VACCINE AVAILABILITY: MAJOR BARRIERS AND IMPEDIMENTS""; ""Impediments to Vaccine Innovation""; ""ECONOMIC CHARACTERISTICS OF THE VACCINE INDUSTRY""; ""VACCINE INJURY""; ""THE LEGAL SITUATION AND ITS CONSEQUENCES""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""A NATIONAL VACCINE COMMISSION""; ""COMPENSATION AND LIABILITY FOR VACCINE-RELATED INJURY""; ""2 Vaccines: Past, Present, and Future"" ""TYPES OF IMMUNIZATION""""HISTORY OF IMMUNIZATION""; ""THE PRESENT""; ""Development of Vaccines and Recommendations for Vaccine Use""; ""THE FUTURE""; ""REFERENCES AND NOTES""; ""3 Vaccine Availability: Concerns, Barriers, and Impediments""; ""CONCERNS ABOUT THE CURRENT SITUATION""; ""Supply""; ""Stockpiling of Vaccines""; ""Problems with Sole Reliance on Foreign Manufacturers""; ""Federal Action to Ensure Vaccine Supply""; ""BARRIERS AND IMPEDIMENTS TO VACCINE INNOVATION""; ""Identification of Need and Establishing Priorities"" ""Establishing the Technical Feasibility of Vaccine Development""""Economic Disincentives to Innovation and Production""; ""Factors Influencing the Market for Vaccines""; ""VACCINE UTILIZATION""; ""System Factors""; ""Client Factors""; ""Provider Factors""; ""CONCLUSIONS""; ""Barriers and Impediments to Vaccine Innovation""; ""REFERENCES AND NOTES""; ""4 Economic Aspects of Vaccine Innovation and Manufacturing""; ""POTENTIAL CAUSES OF INDUSTRY DECLINE""; ""Property Rights and Innovation""; ""Regulation""; ""Market Size""; ""Liability and Risk""; ""DESCRIPTIVE STATISTICS"" ""The Market and Participants""""Pricing""; ""Research and Development""; ""CONCLUSIONS""; ""REFERENCES AND NOTES""; ""5 Vaccine Injury""; ""The Pertussis Controversy""; ""Identifying Individuals at High Risk of Adverse Effects""; ""VACCINES USED IN CHILDHOOD""; ""Pertussis Vaccine""; ""Diphtheria Toxoid""; ""Tetanus Toxoid""; ""Poliomyelitis Vaccines""; ""Measles Vaccine""; ""Rubella Vaccine""; ""Mumps Vaccine""; ""VACCINES FOR ADULTS""; ""Influenza Vaccines""; ""Pneumococcal Vaccines""; ""Meningococcal Vaccines""; ""Rabies Vaccine""; ""Hepatitis B Vaccine""; ""SUMMARY"" Vaccines Government policy United States. Vaccines Technological innovations. Vaccination Complications. http://id.loc.gov/authorities/subjects/sh85141710 Medical policy. http://id.loc.gov/authorities/subjects/sh85083002 Vaccines supply & distribution https://id.nlm.nih.gov/mesh/D014612Q000600 Vaccination trends https://id.nlm.nih.gov/mesh/D014611Q000639 Vaccination adverse effects https://id.nlm.nih.gov/mesh/D014611Q000009 Health Policy https://id.nlm.nih.gov/mesh/D006291 Vaccins Politique gouvernementale États-Unis. Vaccins Innovations. Vaccination Complications et séquelles. Politique sanitaire. MEDICAL Health Risk Assessment. bisacsh MEDICAL Epidemiology. bisacsh Vaccination Complications fast Medical policy fast Vaccines Government policy fast Vaccines Technological innovations fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85141710 http://id.loc.gov/authorities/subjects/sh85083002 https://id.nlm.nih.gov/mesh/D014612Q000600 https://id.nlm.nih.gov/mesh/D014611Q000639 https://id.nlm.nih.gov/mesh/D014611Q000009 https://id.nlm.nih.gov/mesh/D006291 https://id.nlm.nih.gov/mesh/D014481 |
| title | Vaccine supply and innovation / |
| title_auth | Vaccine supply and innovation / |
| title_exact_search | Vaccine supply and innovation / |
| title_full | Vaccine supply and innovation / Division of Health Promotion and Disease Prevention, Institute of Medicine. |
| title_fullStr | Vaccine supply and innovation / Division of Health Promotion and Disease Prevention, Institute of Medicine. |
| title_full_unstemmed | Vaccine supply and innovation / Division of Health Promotion and Disease Prevention, Institute of Medicine. |
| title_short | Vaccine supply and innovation / |
| title_sort | vaccine supply and innovation |
| topic | Vaccines Government policy United States. Vaccines Technological innovations. Vaccination Complications. http://id.loc.gov/authorities/subjects/sh85141710 Medical policy. http://id.loc.gov/authorities/subjects/sh85083002 Vaccines supply & distribution https://id.nlm.nih.gov/mesh/D014612Q000600 Vaccination trends https://id.nlm.nih.gov/mesh/D014611Q000639 Vaccination adverse effects https://id.nlm.nih.gov/mesh/D014611Q000009 Health Policy https://id.nlm.nih.gov/mesh/D006291 Vaccins Politique gouvernementale États-Unis. Vaccins Innovations. Vaccination Complications et séquelles. Politique sanitaire. MEDICAL Health Risk Assessment. bisacsh MEDICAL Epidemiology. bisacsh Vaccination Complications fast Medical policy fast Vaccines Government policy fast Vaccines Technological innovations fast |
| topic_facet | Vaccines Government policy United States. Vaccines Technological innovations. Vaccination Complications. Medical policy. Vaccines supply & distribution Vaccination trends Vaccination adverse effects Health Policy United States Vaccins Politique gouvernementale États-Unis. Vaccins Innovations. Vaccination Complications et séquelles. Politique sanitaire. MEDICAL Health Risk Assessment. MEDICAL Epidemiology. Vaccination Complications Medical policy Vaccines Government policy Vaccines Technological innovations |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=14728 |
| work_keys_str_mv | AT osbornjunee vaccinesupplyandinnovation AT instituteofmedicineusdivisionofhealthpromotionanddiseaseprevention vaccinesupplyandinnovation |